Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGAV | P06756 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7698815 | 1.00 | MAPT (0.54) | MAPTSMN1; SMN2TP53LPAR2NPC1 | |
| SCHEMBL7696532 | 0.92 | SMN1; SMN2 (0.54) | MAPTSMN1; SMN2TP53LPAR2NPC1 | |
| SCHEMBL7696529 | 0.92 | SMN1; SMN2 (0.54) | MAPTSMN1; SMN2TP53LPAR2NPC1 | |
| SCHEMBL7692451 | 0.89 | SMN1; SMN2 (0.55) | MAPTSMN1; SMN2TP53NPC1RAB9A | |
| SCHEMBL7698837 | 0.89 | SMN1; SMN2 (0.55) | MAPTSMN1; SMN2TP53NPC1RAB9A | |
| SCHEMBL7085647 | 0.89 | SMN1; SMN2 (0.59) | MAPTSMN1; SMN2TP53NPC1RAB9A | |
| SCHEMBL7089468 | 0.89 | SMN1; SMN2 (0.59) | MAPTSMN1; SMN2TP53NPC1RAB9A | |
| SCHEMBL7085654 | 0.89 | SMN1; SMN2 (0.59) | MAPTSMN1; SMN2TP53NPC1RAB9A | |
| SCHEMBL7694033 | 0.89 | SMN1; SMN2 (0.55) | MAPTSMN1; SMN2TP53NPC1RAB9A | |
| SCHEMBL7695794 | 0.89 | SMN1; SMN2 (0.52) | MAPTSMN1; SMN2TP53NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6291499-B1 | TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE | MERCK & CO., INC. | 2001-09-18 | — | — | US | claimed |
| US-6495561-B2 | TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE | MERCK & CO., INC. | 2002-12-17 | — | — | US | disclosed |
| US-6380205-B1 | QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN | MERCK & CO., INC. | 2002-04-30 | — | — | US | disclosed |
| US-6291499-B1 | TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE | MERCK & CO., INC. | 2001-09-18 | — | — | US | disclosed |